Today in the U.S. the narrative of the “bad drug” has become quite a familiar account. There is an ever-growing collection of pharmaceutical products whose safety and efficacy has been debunked through the scandalous exposure of violations of integrity on the part of researchers, lapses in procedure and judgment on the part of the FDA, and reckless profiteering on the part of big pharma. However, a closer look reveals that the oversights and loopholes depicted in the bad drug narrative are not incidental failures of an otherwise intact, effective system.
Download count: 0
- Partial requirement for: M.S., Arizona State University, 2015Note typethesis
- Includes bibliographical references (pages 71-78)Note typebibliography
- Field of study: Sociology